Pricing Log in Create free account

Electromed, Inc. (ELMD) vs TriSalus Life Sciences, Inc. (TLSI)

Electromed, Inc. and TriSalus Life Sciences, Inc. are both Medical Devices companies. Electromed, Inc. and TriSalus Life Sciences, Inc. are of similar size ($240.1M and $232.3M). TriSalus Life Sciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Electromed, Inc. trades at 20.0×. TriSalus Life Sciences, Inc. grew revenue faster over the last twelve months: 25.3% against 15.3%. Electromed, Inc. has the higher net margin (15.3% vs −127.0%) and the higher return on invested capital (25.9% vs 0.00%). Across the 18 metrics below, Electromed, Inc. leads on 14 and TriSalus Life Sciences, Inc. on 4.

Valuation

Metric ELMD TLSI Medical Devices median
P/E 20.01 n/m 23.22
P/S 3.07 4.69 2.34
P/B 4.20 32.31 2.33
Price to free cash flow 27.10 n/m 23.72
EV/EBITDA 13.86 n/m 11.54
EV/Sales 2.81 4.41 2.24
Earnings yield 5.00% (35.81%) (10.09%)
Free cash flow yield 3.69% (11.33%) (8.47%)

Profitability

Metric ELMD TLSI Medical Devices median
Gross margin 78.54% 85.79% 56.01%
Operating margin 18.82% (67.68%) (15.03%)
Net margin 15.32% (127.00%) (20.40%)
Free cash flow margin 11.34% (51.56%) (7.24%)
Return on equity 23.26% 889.44% (15.32%)
Return on assets 18.82% (110.34%) (19.72%)
Return on invested capital 25.87% 0.00% (10.33%)

Growth

Metric ELMD TLSI Medical Devices median
Revenue growth (TTM) 15.28% 25.25% 8.80%
EPS growth (last fiscal year) 52.94% (40.46%) 29.03%
Revenue growth, 5-year CAGR 15.59% — 15.47%
Net income growth, 5-year CAGR 36.76% 0.00% 0.00%

Health

Metric ELMD TLSI Medical Devices median
Debt to equity 0.00 5.05 0.07
Current ratio 4.69 5.35 2.50
Net debt to EBITDA (1.37) (0.50) 0.49

Dividend

Metric ELMD TLSI Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric ELMD TLSI Medical Devices median
Market cap 232.29m 240.14m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack